Multiple early factors anticipate post-acute COVID-19 sequelae

Area of Science:

• Immunology
• Virology
• Endocrinology
• Genomics

Background:

• Post-acute sequelae of COVID-19 (PASC) is a growing global health concern.
• Quantifiable risk factors and biological underpinnings of PASC remain incompletely understood.

Purpose of the Study:

• To identify quantifiable risk factors for PASC.
• To explore the biological associations and immunological signatures of PASC.
• To investigate the longitudinal changes in immune states during COVID-19 convalescence.

Main Methods:

• A deep multi-omic, longitudinal study of 309 COVID-19 patients from diagnosis to 2-3 months post-recovery.
• Integration of clinical data and patient-reported symptoms with multi-omic data.
• Analysis of immunological signatures, including SARS-CoV-2 and CMV-specific CD8+ T cells, and auto-antibodies.

Main Results:

• Four PASC-predicting risk factors identified at initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies.
• Distinct dynamics of SARS-CoV-2 and CMV-specific CD8+ T cells observed in patients with gastrointestinal PASC.
• Four immunological endotypes identified, correlating with acute severity and PASC development.
• Immunological associations between PASC factors diminish over time, leading to distinct convalescent immune states.

Conclusions:

• Early identification of specific risk factors at the time of COVID-19 diagnosis is crucial for predicting and understanding PASC.
• Immunological signatures and T cell dynamics offer insights into PASC pathogenesis.
• Understanding longitudinal immune changes is key to developing effective PASC treatment strategies.